VOYA Investment Management’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,392
Closed -$243K 2821
2023
Q4
$243K Sell
8,392
-238
-3% -$6.37K ﹤0.01% 2470
2023
Q3
$231K Sell
8,630
-3,271
-27% -$112K ﹤0.01% 2460
2023
Q2
$441K Buy
11,901
+191
+2% +$6.66K ﹤0.01% 2154
2023
Q1
$366K Hold
11,710
﹤0.01% 2214
2022
Q4
$349K Sell
11,710
-8,664
-43% -$310K ﹤0.01% 2231
2022
Q3
$777K Buy
20,374
+2,487
+14% +$125K ﹤0.01% 1768
2022
Q2
$976K Hold
17,887
﹤0.01% 1417
2022
Q1
$1.12M Buy
17,887
+3,821
+27% +$252K ﹤0.01% 1414
2021
Q4
$1.42M Sell
14,066
-579
-4% -$50.9K ﹤0.01% 1343
2021
Q3
$1.32M Buy
14,645
+199
+1% +$18.1K ﹤0.01% 1392
2021
Q2
$1.33M Buy
14,446
+3,526
+32% +$282K ﹤0.01% 1431
2021
Q1
$1.05M Buy
10,920
+2,173
+25% +$224K ﹤0.01% 1554
2020
Q4
$456K Buy
+8,747
New +$365K ﹤0.01% 1981

Other funds holding FLGT

VOYA Investment Management's FLGT Position: Q1 2024 in Review

VOYA Investment Management sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 8,392 shares — an estimated $243K sold.

VOYA Investment Management first reported a position in FLGT in Q4 2020 and held it in 13 quarters. The position peaked at $1.42M in Q4 2021. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • VOYA Investment Management reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • VOYA Investment Management sold 8,392 Fulgent Genetics shares in Q1 2024, an estimated $243K.
  • VOYA Investment Management first reported a position in Fulgent Genetics in Q4 2020 and held it in 13 quarters.
  • VOYA Investment Management's Fulgent Genetics position peaked at $1.42M in Q4 2021.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.